Delivery Order SPE2DB22D2214-SPE2DB25FS6FD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, valued at $13,527.84 on August 12, 2025, with completion expected by August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Valtoco is a rescue medication used in acute seizure management, representing the specialized pharmaceutical products that support...
- The Defense Logistics Agency awarded a delivery order valued at $4,504.40 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizures, representing specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a $1,747.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract was issued on August 11, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Valtoco is a prescription nasal spray medication used for acute seizure management, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $4,107.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in epilepsy patients,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with performance in Conshohocken, Pennsylvania and completion by July 23, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing typical of DLA pharmaceutical procurement. Valtoco is a rescue medication indicated for acute repetitive seizure episodes, reflecting the broad therapeutic scope of...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6FDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed from the vendor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved rescue medication indicated for acute repetitive seizures, supporting military and federal healthcare system needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through consistent competitive awards across multiple therapeutic domains, positioning it as a critical vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/25 |